Showing 60,601 - 60,620 results of 62,523 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (we decrease)) ))', query time: 1.10s Refine Results
  1. 60601
  2. 60602
  3. 60603
  4. 60604

    Table_1_Causal Association and Shared Genetics Between Asthma and COVID-19.xlsx by Ancha Baranova (207327)

    Published 2022
    “…</p>Conclusion<p>In conclusion, our results suggest that genetic liability to asthma is associated with decreased susceptibility to SARS-CoV-2 and to severe COVID-19 disease, which may be due to the protective effects of ongoing inflammation and, possibly, related compensatory responses against COVID-19 in its early stage.…”
  5. 60605
  6. 60606
  7. 60607
  8. 60608
  9. 60609
  10. 60610

    DataSheet1_Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.DOCX by Andrea Vannini (571959)

    Published 2024
    “…So far, only one nectin4-specific drug—Enfortumab Vedotin—has been approved and the clinical trials that test novel therapeutics are only five. Here we engineered R-421, an innovative retargeted onco-immunotherapeutic herpesvirus highly specific for nectin4 and unable to infect through the natural herpes receptors, nectin1 or herpesvirus entry mediator. …”
  11. 60611
  12. 60612

    Table 3_Transcriptomic analysis reveals the key role of inflammatory and immune signaling in the anti-perimenopausal depression effects of Bushen Shugan Huayu decoction.pdf by Ziqin Feng (22318243)

    Published 2025
    “…</p>Results<p>Following BSSGHY decoction treatment, patients showed a significant reduction in HAMD scores (p < 0.01), marked symptom relief (p < 0.05), and decreased inflammatory factor levels (p < 0.01). We then conducted RNA-SEQ analysis before and after treatment in patients with perimenopausal depression. …”
  13. 60613

    DataSheet1_Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.DOCX by Andrea Vannini (571959)

    Published 2023
    “…So far, only one nectin4-specific drug—Enfortumab Vedotin—has been approved and the clinical trials that test novel therapeutics are only five. Here we engineered R-421, an innovative retargeted onco-immunotherapeutic herpesvirus highly specific for nectin4 and unable to infect through the natural herpes receptors, nectin1 or herpesvirus entry mediator. …”
  14. 60614

    Table 1_Transcriptomic analysis reveals the key role of inflammatory and immune signaling in the anti-perimenopausal depression effects of Bushen Shugan Huayu decoction.docx by Ziqin Feng (22318243)

    Published 2025
    “…</p>Results<p>Following BSSGHY decoction treatment, patients showed a significant reduction in HAMD scores (p < 0.01), marked symptom relief (p < 0.05), and decreased inflammatory factor levels (p < 0.01). We then conducted RNA-SEQ analysis before and after treatment in patients with perimenopausal depression. …”
  15. 60615

    DataSheet_1_Do submerged macrophyte species influence crustacean zooplankton functional group richness and their resource use efficiency in the low-light environment?.docx by Li Wang (15202)

    Published 2023
    “…Specifically, zooplankton functional group (i.e., pelagic species, plant-associated species, and substrate scrapers) richness and zooplankton species diversity decreased with the decreasing light intensity, especially for low substrate scraper abundance. …”
  16. 60616
  17. 60617

    Table_1_Algal amendment enhances biogenic methane production from coals of different thermal maturity.DOCX by George A. Platt (14770780)

    Published 2023
    “…However, little is known about how the addition of algal biomass amendment affects methane production from coals of different thermal maturity. Here, we show that biogenic methane can be produced from five coals ranging in rank from lignite to low-volatile bituminous using a coal-derived microbial consortium in batch microcosms with and without algal amendment. …”
  18. 60618

    Table 6_Transcriptomic analysis reveals the key role of inflammatory and immune signaling in the anti-perimenopausal depression effects of Bushen Shugan Huayu decoction.pdf by Ziqin Feng (22318243)

    Published 2025
    “…</p>Results<p>Following BSSGHY decoction treatment, patients showed a significant reduction in HAMD scores (p < 0.01), marked symptom relief (p < 0.05), and decreased inflammatory factor levels (p < 0.01). We then conducted RNA-SEQ analysis before and after treatment in patients with perimenopausal depression. …”
  19. 60619
  20. 60620